Daniel Furst, MD
Enriched profileProfessor of Medicine, Emeritus, David Geffen School of Medicine at UCLA, Division of Rheumatology (also in active clinical practice at Pacific Arthritis Care Center of Los Angeles) · Pacific Arthritis Care Center of Los Angeles
Daniel Furst is Professor of Medicine, Emeritus, David Geffen School of Medicine at UCLA, Division of Rheumatology (also in active clinical practice at Pacific Arthritis Care Center of Los Angeles) at Pacific Arthritis Care Center of Los Angeles. OpenAlex indexes 364 publications with 34,660 citations (h-index 82); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Rheumatology profiles in the findmyKOL directory. Clarivate lists Daniel Furst as a Highly Cited Researcher (Clinical Medicine, 2015-2016).
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Daniel E. Furst, MD, is Professor of Medicine, Emeritus, David Geffen School of Medicine at UCLA, Division of Rheumatology (also in active clinical practice at Pacific Arthritis Care Center of Los Angeles). The public record shows 364 publications with 34,660 citations (h-index 82), centered on Rheumatology/Immunology. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 39 companies, 2 NIH-funded awards (1985–2009).
- Most recent indexed publication: 2026 · Clinical rheumatology
- Top research focus: Rheumatology/Immunology
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 39 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Morbidity and Mortality Follow Up for the Scleroderma Lung Study
Sponsor: Duke University
- SCOT Scleroderma Treatment Alternative Registry (STAR Registry)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Industry payments
Updated 27 Aug 2026
39 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- SOBI, INCProgram year20253 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20253 payments
- E.R. Squibb & Sons, L.L.C.Program year20253 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
29.9%Proton pump inhibitor10.5%Omeprazole54%Lansoprazole23%Pantoprazole Sodium23%Part D<11 patientsH2 blocker6.9%Famotidine100%Part D≥21 patientsNervous system
26.1%Gabapentinoids9%Gabapentin70%Pregabalin30%Part D<11 patientsBenzodiazepine5.5%Alprazolam63%Clonazepam37%Part D<11 patientsCardiovascular
18.9%Statin4.9%Rosuvastatin Calcium58%Atorvastatin Calcium42%Part D<11 patientsACE inhibitor4.5%Lisinopril60%Enalapril Maleate40%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 1985–2009 per NIH RePORTER. The latest:
- Provisional Combined Response Index For Patients With Diffuse Systemic Sclerosis
University of California Los Angeles
FY2009$348,649U01AR055057 - Provisional Combined Response Index For Patients With Diffuse Systemic Sclerosis
University of California Los Angeles
FY2008$348,512U01AR055057 - Provisional Combined Response Index For Patients With Diffuse Systemic Sclerosis
University of California Los Angeles
FY2007$243,152U01AR055057
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Rheumatoid arthritis in crisis: investigating the impact of stress on RA flares during the COVID-19 pandemic.
Clinical rheumatology
Article2026 - Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years.
Rheumatology and therapy
Article2024 - Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis.
Rheumatology and therapy
Article2022 - The burning question: To use or not to use cyclophosphamide in systemic sclerosis.
European journal of rheumatology
Review2020
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/daniel-furst-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Daniel-Furst-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/daniel-furst-19716017a
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
furstrheum.com
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →furstrheum.com ↗ - Other
buzzsprout.com/2318677/episodes/15236152-navigating-systemic-sclerosis-signs-symptoms-updates-on-treatment-with-professor-dr-daniel-furst
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →buzzsprout.com ↗ - YouTube
m.youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →m.youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Johns Hopkins University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pacificarthritis.com ↗ - Fellowship in Rheumatology
UCLA Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →expertperspectives.com ↗ - Fellowship in Clinical Pharmacology
UCSF Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →expertperspectives.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →perspectivesinrheumaticdiseases.com ↗
Editorial & leadership roles
journal and society appointments- National Medical Advisory Board
Scleroderma Foundation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →expertperspectives.com ↗ - Scientific Advisory Board
Arthritis Foundation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →expertperspectives.com ↗ - Board of Directors
Collaboration of Research Rheumatologists of North America (CORRONA foundation)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →expertperspectives.com ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Clinical Medicine20152016verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →perspectivesinrheumaticdiseases.com ↗
- First Carl M. Pearson Professor of Medicine
UCLA Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pacificarthritis.com ↗
Secondary affiliations
appointments beyond the home institution- Adjunct Professor
University of Washington, Seattle
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →expertperspectives.com ↗ - Research Professor
University of Florence, Italy
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Media & interviews
press, podcasts and appearances- Podcast guest
"Thriving with Arthritis and Autoimmune Diseases" with Dr. Diana Girnita, episode on systemic sclerosis signs, symptoms, and treatment updates
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →buzzsprout.com ↗ - Video interview
EULAR23 conference, interviewed by Dr. Chiara Bellocchi
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - Video interview on scleroderma/COVID-19
"Stream for a Cure" (with Elaine Furst)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University